東華軟件(002065.SZ):控股子公司與浙江德塔森特簽署戰略合作框架協議
格隆匯 6 月 22日丨東華軟件(002065.SZ)公佈,2020年6月21日,東華軟件股份公司(以下簡稱“公司”)控股子公司東華電子信息產業(寧波)有限公司與浙江德塔森特數據技術有限公司本着平等互利、優勢互補的原則,就雙方今後在鵬霄服務器及行業一體機應用推廣等領域建立戰略合作關係,簽署了《東華電子信息產業(寧波)有限公司與浙江德塔森特數據技術有限公司的合作框架協議》(以下簡稱“戰略合作框架協議”)。
合作條款:甲、乙雙方承諾在各自項目中優先考慮採購對方產品,乙方雲運維平台數據中心建設優先採購鵬霄服務器作為硬件底座,12月31日前採購數量不低於1000台,屆時另行簽訂採購協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.